Kesios Therapeutics
Develops novel therapeutics for the treatment of multiple myeloma and other cancers
Kesios Therapeutics has raised €27M across 1 funding round from 3 investors, most recently a Series A round in Dec 2015. Based in London, UK; founded 2012; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€27M
€26,958,002
Funding rounds
1
Investors
3
distinct backers
Active since
2015-12
latest 2015-12
Funding by year
EUR raised per yearKesios Therapeutics — funding by year — interactive chart.
Data table
| Kesios Therapeutics — funding by year | |
|---|---|
| 2015 | €27M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-12-01 | Series A | €27M | Abingworth LLP,Imperial Innovations Limited,SV Life Sciences | View deal → |
Similar companies
same sector or countryGlobal coverage: FundingData